Evidence map›Paper›PMID 35308147›Full record

ArticleDiabetes spectrum : a publication of the American Diabetes Association2022

Telehealth Technologies and Their Benefits to People With Diabetes.

Chinenye O Usoh, Kristine Kilen, Carolyn Keyes, Crystal Paige Johnson, Joseph A Aloi

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes spectrum : a publication of the American Diabetes Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Direct-to-Consumer Testing: Relevance for Diabetes Therapy.Journal of diabetes science and technology · 2025
    Article
  2. Review
  3. Effect of COVID-19 on Type 2 Diabetes Self-Care Behaviors: A Rapid Review.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chinenye O UsohDivision of Endocrinology, Diabetes and Metabolism, Wake Forest University School of Medicine, Winston-Salem, NC.ORCID https://orcid.org/0000-0002-0697-9753
Kristine KilenNovo Nordisk, Plainsboro, NJ.
Carolyn KeyesDivision of Endocrinology, Diabetes and Metabolism, Wake Forest University School of Medicine, Winston-Salem, NC.
Crystal Paige JohnsonDivision of Endocrinology, Diabetes and Metabolism, Wake Forest University School of Medicine, Winston-Salem, NC.
Joseph A AloiDivision of Endocrinology, Diabetes and Metabolism, Wake Forest University School of Medicine, Winston-Salem, NC.
Wake Forest University · USNovo Nordisk (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article reviews the current diabetes technology landscape and how recent advancements are being used to help overcome barriers in the management of diabetes. The authors offer case examples of how digital tools and platforms can facilitate diabetes care via telehealth and remote patient monitoring for individuals in special populations. They also provide tips to ensure success in implementing diabetes technology to provide the best possible care for people with diabetes in outpatient settings.

Identifiers

PMID35308147
PMCPMC8914588
OpenAlexW4220966356

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.